Financial reports
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
25 Apr 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
Current reports
8-K
Regulation FD Disclosure
12 Mar 24
8-K
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
22 Feb 24
8-K
Results of Operations and Financial Condition
11 Jan 24
8-K
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
3 Jan 24
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
6 Dec 23
8-K
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
3 Nov 23
8-K
Results of Operations and Financial Condition
12 Oct 23
8-K
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
26 Sep 23
8-K
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
22 Feb 24
424B5
Prospectus supplement for primary offering
3 May 23
424B5
Prospectus supplement for primary offering
2 May 23
D
$100.00 mm in equity, sold $100.00 mm, 4 investors
1 Mar 23
S-3ASR
Automatic shelf registration
23 Feb 23
S-8
Registration of securities for employees
23 Feb 23
S-8
Registration of securities for employees
24 Feb 22
RW
Registration withdrawal request
13 Aug 21
S-3ASR
Automatic shelf registration
11 Aug 21
RW WD
Withdrawal of registration withdrawal request
11 Aug 21
Proxies
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
PRE 14A
Preliminary proxy
10 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
4 May 20
DEF 14A
Definitive proxy
30 Apr 20
Other
EFFECT
Notice of effectiveness
9 Jul 20
CORRESP
Correspondence with SEC
6 Jul 20
UPLOAD
Letter from SEC
2 Jul 20
EFFECT
Notice of effectiveness
27 Jun 19
SEC STAFF
SEC staff action: Order
25 Jun 19
CORRESP
Correspondence with SEC
24 Jun 19
CORRESP
Correspondence with SEC
24 Jun 19
CERT
Certification of approval for exchange listing
21 Jun 19
CORRESP
Correspondence with SEC
14 Jun 19
UPLOAD
Letter from SEC
10 Jun 19
Ownership
4
Bruce Rogers
28 Mar 24
4
Simon Peter Cooper
19 Mar 24
3
Simon Peter Cooper
19 Mar 24
SC 13G/A
EcoR1 Capital, LLC
15 Feb 24
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
SC 13G/A
Polaris Partners VII, L.P.
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24